Works matching DE "BREAKTHROUGH infections"
Results: 778
Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18651
- By:
- Publication type:
- Article
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification.
- Published in:
- Virus Evolution, 2024, v. 10, n. 1, p. 1, doi. 10.1093/ve/veae071
- By:
- Publication type:
- Article
Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-88048-7
- By:
- Publication type:
- Article
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and Vaccinated.
- Published in:
- Journal of Infectious Diseases, 2025, v. 231, n. 1, p. 115, doi. 10.1093/infdis/jiae484
- By:
- Publication type:
- Article
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, Sweden.
- Published in:
- Journal of Infectious Diseases, 2025, v. 231, n. 1, p. e195, doi. 10.1093/infdis/jiae463
- By:
- Publication type:
- Article
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56302-1
- By:
- Publication type:
- Article
Correction: Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
AI-Enhanced Strategies for COVID-19 Vaccination and Booster Prioritization: A Comprehensive Framework.
- Published in:
- National Journal of Community Medicine, 2024, v. 15, n. 12, p. 1013, doi. 10.55489/njcm.151220244270
- By:
- Publication type:
- Article
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection.
- Published in:
- Science Translational Medicine, 2025, v. 17, n. 783, p. 1, doi. 10.1126/scitranslmed.adq1086
- By:
- Publication type:
- Article
Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections.
- Published in:
- Mycopathologia, 2023, v. 188, n. 4, p. 401, doi. 10.1007/s11046-023-00768-4
- By:
- Publication type:
- Article
Low‐frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled‐edged sword.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 7, p. 3192, doi. 10.1002/jmv.27726
- By:
- Publication type:
- Article
Adverse events and breakthrough infections associated with COVID‐19 vaccination in the Indian population.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 7, p. 3147, doi. 10.1002/jmv.27708
- By:
- Publication type:
- Article
Survey of fully vaccinated anti‐COVID 19 people from June to November 2021: Single Italian center study.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 7, p. 2919, doi. 10.1002/jmv.27690
- By:
- Publication type:
- Article
Long‐term immunity in convalescent Syrian hamsters provides protection against new‐variant SARS‐CoV‐2 infection of the lower but not upper respiratory tract.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 6, p. 2833, doi. 10.1002/jmv.27641
- By:
- Publication type:
- Article
SARS‐CoV‐2 breakthrough infection and viral load among healthcare workers after COVID‐19 vaccines.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 6, p. 2350, doi. 10.1002/jmv.27639
- By:
- Publication type:
- Article
Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 5, p. 2237, doi. 10.1002/jmv.27636
- By:
- Publication type:
- Article
Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 4, p. 1300, doi. 10.1002/jmv.27467
- By:
- Publication type:
- Article
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 4, p. 1696, doi. 10.1002/jmv.27461
- By:
- Publication type:
- Article
Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD<sup>TM</sup>) recipients: Report from the eastern state of India.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 3, p. 1201, doi. 10.1002/jmv.27382
- By:
- Publication type:
- Article
Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): A preliminary analysis from north India.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 1, p. 407, doi. 10.1002/jmv.27320
- By:
- Publication type:
- Article
Non-Antibiotic Prophylaxis for Recurrent UTIs in Neurogenic Lower Urinary Tract Dysfunction (NAPRUN): Study Protocol for a Prospective, Longitudinal Multi-Arm Observational Study.
- Published in:
- Methods & Protocols, 2023, v. 6, n. 3, p. 52, doi. 10.3390/mps6030052
- By:
- Publication type:
- Article
Is Measurement of Systemic IgG Antibodies the Wrong Way to Assess COVID-19 Vaccine Effectiveness for Breakthrough Infections?<sup> </sup>.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The Challenge of Mpox Diagnosis for the Colorectal Surgeon.
- Published in:
- World Journal of Colorectal Surgery, 2024, v. 13, n. 4, p. 141, doi. 10.4103/wjcs.wjcs_33_24
- By:
- Publication type:
- Article
Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2023, v. 28, n. 2, p. 123, doi. 10.5863/1551-6776-28.2.123
- By:
- Publication type:
- Article
Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 22, p. 2992, doi. 10.3390/healthcare11222992
- By:
- Publication type:
- Article
Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 6, p. 1085, doi. 10.3390/healthcare10061085
- By:
- Publication type:
- Article
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2007, v. 26, n. 11, p. 843, doi. 10.1007/s10096-007-0366-5
- By:
- Publication type:
- Article
Update on COVID‐19 vaccination in pediatric solid organ transplant recipients.
- Published in:
- Pediatric Transplantation, 2022, v. 26, n. 5, p. 1, doi. 10.1111/petr.14235
- By:
- Publication type:
- Article
Objectively measured peri-vaccination sleep does not predict COVID-19 breakthrough infection.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53743-4
- By:
- Publication type:
- Article
Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52748-3
- By:
- Publication type:
- Article
Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47261-y
- By:
- Publication type:
- Article
Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47613-8
- By:
- Publication type:
- Article
Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44616-3
- By:
- Publication type:
- Article
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45718-8
- By:
- Publication type:
- Article
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44565-x
- By:
- Publication type:
- Article
Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 619, doi. 10.1007/s40121-024-00930-5
- By:
- Publication type:
- Article
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 2, p. 367, doi. 10.1007/s40121-022-00753-2
- By:
- Publication type:
- Article
Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 1, p. 177, doi. 10.1007/s40121-022-00711-y
- By:
- Publication type:
- Article
Comparison of breakthrough Gram‐positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1342, doi. 10.1111/jcpt.13215
- By:
- Publication type:
- Article
Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1197671
- By:
- Publication type:
- Article
Structural Insights on the SARS-CoV-2 Variants of Concern Spike Glycoprotein: A Computational Study With Possible Clinical Implications.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.773726
- By:
- Publication type:
- Article
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
- Published in:
- Mycoses, 2023, v. 66, n. 1, p. 35, doi. 10.1111/myc.13524
- By:
- Publication type:
- Article
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016‐B survey.
- Published in:
- Mycoses, 2022, v. 65, n. 2, p. 171, doi. 10.1111/myc.13384
- By:
- Publication type:
- Article
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
- Published in:
- Mycoses, 2021, v. 64, n. 11, p. 1334, doi. 10.1111/myc.13298
- By:
- Publication type:
- Article
Breakthrough invasive fungal infections: Who is at risk?
- Published in:
- Mycoses, 2020, v. 63, n. 10, p. 1021, doi. 10.1111/myc.13148
- By:
- Publication type:
- Article
Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
- Published in:
- Mycoses, 2019, v. 62, n. 9, p. 716, doi. 10.1111/myc.12960
- By:
- Publication type:
- Article
Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections.
- Published in:
- Mycoses, 2015, v. 58, n. 6, p. 362, doi. 10.1111/myc.12326
- By:
- Publication type:
- Article
Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient.
- Published in:
- Mycoses, 2015, v. 58, n. 5, p. 308, doi. 10.1111/myc.12305
- By:
- Publication type:
- Article
Our 2014 approach to breakthrough invasive fungal infections.
- Published in:
- Mycoses, 2014, v. 57, n. 11, p. 645, doi. 10.1111/myc.12213
- By:
- Publication type:
- Article
Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay.
- Published in:
- Mycoses, 2014, v. 57, n. 4, p. 249, doi. 10.1111/myc.12142
- By:
- Publication type:
- Article